CD80 and neoplasm: Although it is not clear from the present analysis which cells are expressing these genes, CD80 is known as an activation marker of monocytes in peripheral blood, suggesting that the activity of monocytes prior to tumor growth is a critical factor affecting the strength of anti-tumor activity induced by the combination with DSP-0509.